Achieve Life Sciences, Inc. (ACHV)
4.69
+0.09
(+1.96%)
USD |
NASDAQ |
May 22, 16:00
4.70
+0.01
(+0.21%)
After-Hours: 20:00
Achieve Life Sciences Cash from Investing (Quarterly) : 14.28M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Aurinia Pharmaceuticals, Inc. | -18.08M |
| Edesa Biotech, Inc. | 0.00 |
| Xenon Pharmaceuticals, Inc. | -407.28M |
| ProMIS Neurosciences, Inc. | 0.00 |
| Medicus Pharma Ltd. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.932M |
| Cash from Financing (Quarterly) | 0.021M |
| Free Cash Flow | -45.31M |
| Free Cash Flow Per Share (Quarterly) | -0.1299 |
| Free Cash Flow to Equity (Quarterly) | -6.929M |
| Free Cash Flow to Firm (Quarterly) | -6.658M |
| Free Cash Flow Yield | -20.09% |